Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bernard P, Bedane C, Mounier M et al (1995) Bacterial dermo-hypodermatitis in adults. IncIDence and role of streptococcal etiology. Ann Dermatol Venereol 122: 495–500
Bisno A, Stevens D (1996) Streptococcal infections of skin and soft tissuesN Engl J Med 334:240–245
Consensus conference: Management of erysipelas and necrotizing fasciitis (2001) Ann Dermatol Venereol 128:463–482
Bernard P, Bedane C, Mounier M et al (1989) Streptococcal cause of erysipelas and cellulitis in adults: a microbiologic study using a direct immunofluorescence technique. Arch Dermatol 125:779–782
Leppard BJ, Seal DV, Colman G (1985) The value of bacteriology and serology in the diagnosis of cellulitis and erysipelas. Br J Dermatol 112:559–567
Goettsch WG, Bouwes Bavinck JN, Herings RMC (2006) Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol 20:834–839
Dupuy A, Benchikhi H, Roujeau JC et al (1999) Risk factors for erysipelas of the leg (cellulitis): case-control study. Br Med J 318:1591–1594
Roujeau JC, Paul C et al (2004) Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case control study. Dermatology 209:301–307
Ronnen M, Suster S, Schewach-Millet et al (1985) Erysipelas: changing faces. Int J Dermatol 24:169–172
Crickx B, Chevron F, Sigal-Nahum M et al (1991) Erysipelas: epIDemiological, clinical and therapeutic data (111 cases). Ann Dermatol Venereol 118:11–16
Leclerc S, Teixeira A Mahé E et al (2007) Recurrent erysipelas: 47 cases. Dermatology 214:52–57
Vignes S, Dupuy A (2006) Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibio-therapy: a retrospective cohort study. J Eur Acad Dermatol 20:818–822
Coste N, Perceau G, Leone J et al (2004) Osteoarticular complications of erysipelas. J Am Acad Dermatol 50:203–209
Kopp M, Bernard P, Schmit JL (2001) [Dealing with bacterial hypodermal infection in general practice: an inquiry and a prospective study]. Ann Dermatol Venereol 128: 338–344
Musette P, Benichou J, Noblesse I et al (2004) Determinants of severity for superficial cellutitis (erysipelas) of the leg: a retrospective study. Eur J Intern Med 15:446–450
Jegou J, Hansmann Y, Chalot F et al (2002) Hospitalization criteria for erysipelas: prospective study in 145 cases. Ann Dermatol Venereol 129:375–379
Stevens DL, Bisno AL, Chambers HF et al (2005). Practice guIDelines for the management of skin and soft tissue infections. Clin Infect Dis 41:1373–1406
Jorup-Rönström C, Britton C, Gavlevik A et al (1984) The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas. Infection 12:390–394
Bernard P, ChosIDow O, Vaillant L (2002) Oral pristinamy-cin versus standard penicillin regimen to treat erysipelas in adult patients: randomised, non-inferiority, open trial. Br Med J 325:864–866
Estines O, Coste N, Perceau G et al (2003) [Haemorrhagic cellulitis: three cases]. Ann Dermatol Venereol 130:523–526
Heng MC, Khoo M, Cooperman A, Fallon-Friedlander S (1994) Haemorragic cellulitis: a syndrome associated with tumour necrosis factor-alpha. Br J Dermatol 130:65–74
Moran GJ, Krishnadasan A, Gorwitz RJ et al (2006) Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355:666–674
Gabillot-Carré M, Roujeau JC (2007) Acute bacterial skin infections and cellulitis. Curr Opin Infect Dis 20:118–123
Phillips S, MacDougall C, Holdford DA et al (2007) Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus. Ann Pharmacother 41:13–20
Hasham S, Matteuci P, Stanley PR et al (2005) Necrotising fasciitis. Br Med J 330:830–833
Liu YM, Chi CY, Ho MW et al (2005) Microbiology and factors affecting mortality in necrotizing fasciitis. J Microbiol Immunol Infect 38:430–435
Miller LG, Perdreau-Remington F, Rieg G et al (2005) Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352:1445–1453
Kaul R, McGeer A, Low DE et al (1997) Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario group A Streptococcal study. Am J Med 103:18–24
Zerr DM, Alexander ER, Duchin JS et al (1999) A case-control study of necrotizing fasciitis during primary varicella. Pediatrics 103:783–790
Aronoff DM, Bloch KC (2003) Assessing the relationship between the use of nonsteroIDal anti-inflammatory drugs and necrotizing fasciitis caused by group A streptococcus. Medicine (Baltimore) 82:225–235
Revelon G, Rhamouni A, Jazaerli X et al (1999) Acute swelling of the limbs: magnetic resonance pictorial review of fascial and muscle signal changes. Eur J Radiol 30:11–21
Saiag P, LeBreton C, Pavlovic M et al (1994) Magnetic resonance imaging in adults presenting with severe acute infectious cellulitis. Arch Dermatol 130:1150–1158
Golger A, Ching S, Goldsmith CH et al (2007) Mortality in patients with necrotizing fasciitis. Plast Reconstr Surg 119:1803–1807
Voros D, Pissiotis C, Antoniou S et al (1993) Role of early and extensive surgery in the treatment of severe necrotizing soft tissue infection. Br J Surg. 80:1190–1191
Société de Pathologie Infectieuse de Langue Française (2007) Short text. Management of diabetic foot infections. Med Mal Infect 37:1–25
International Working Group on the Diabetic Foot (2003) International consensus on the diabetic foot [CD-ROM]. In: International Diabetes Foundation; Brussels. http// www.iwgdf.org
Lipsky BA, Berendt AR, Embil J, De Lalla F (2004) Diagnosing and treating diabetic foot infections. Diab Metab Res Rev 20:s56–s64
Lavery A, Harkless LB, Felder-Johnsn K, Mundine S (1994) Bacterial pathogens in infected puncture wounds in adults with diabetes. J Foot Ankle Surg 33:91–97
El-Tahawy A (2000) Bacteriology of diabetic foot. Saudi Med J 213:44–47
Dang CN, Prasad YDM, Boulton AJ, Jude EB (2003) Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diab Med 20: 159–161
Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J (2005) The global burden of diabetic foot disease. Lancet 336:1719–1724
Lavery LA, Armstrong DG, Wunderlich RP et al (2006) Risk factors for foot infections in indivIDuals with diabetes. Diab Care 29:1288–1293
Capriotti G, Chianelli M, Signore A (2006) Nuclear medicine imaging of diabetic foot infection: results of meta-anal-ysis. Nucl Med Commun 27:757–764
El-Maghraby TA, Moustafa HM, Pauwels EK (2006) Nuclear medicine methods for evaluation of skeletal infection among other diagnostic modalities. Q J Nucl Med Mol Imag 50:167–192
Ertrugul MB, Baktiroglu S, Salman S et al (2006) The diagnosis of osteomyelitis of the foot in diabetes: microbiological examination vs. magnetic resonance imaging and labelled leucocyte scanning. Diab Med 23:649–653
Kumar V (2005) Radiolabeled white blood cells and direct targeting of micro-organisms for infection imaging. Q J Nucl Med Mol Imaging 49:325–338
Armstrong DG, Lavery LA, Harkless LB (1998) The contribution of depth, infection and ischemia to risk of amputation. Diab Care 21:855–858
Rao N, Lipsky BA (2007) Optimising antimicrobial therapy in diabetic foot infections. Drugs 67:195–214
Lipsky BA, Sheehan P, Armstrong DG et al (2007) Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial. Int Wound J 4:30–38
Nelson EA, O'Meara S, Golder S et al (2006) Systematic review of antimicrobial treatments for diabetic foot ulcers. Diab Med 23:348–359
Pisky A, Armstrong DG, Citron DM et al (2005) Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trialLancet 366:1695–1703
Cruciani M, Libsky BA, Mengoli C et al (2005) Are granu-locyte colony-stimulating factors beneficial in treating diabetic foot infections? Diab Care 28:454–460
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bernard, P. (2009). Severe Infections of Soft Tissues (Including Fasciitis and Diabetic Foot Infections). In: Revuz, J., Roujeau, JC., Kerdel, F.A., Valeyrie-Allanore, L. (eds) Life-Threatening Dermatoses and Emergencies in Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79339-7_6
Download citation
DOI: https://doi.org/10.1007/978-3-540-79339-7_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-79338-0
Online ISBN: 978-3-540-79339-7
eBook Packages: MedicineMedicine (R0)